Clinical Trial Update: Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract [Phase 4]

View source ↗

Summary

Phase 4 trial assessing additive hemostatic efficacy of EndoClot after EMR or ESD in the GI tract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Dysplasia
• Colonic Neoplasms
• Colonic Polyp

Drugs mentioned

• EndoClot

Snippet

Sponsor: University of Turin, Italy | Conditions: Colonic Polyp, Colonic Neoplasms | Phase 4 | Status: UNKNOWN